Blocking VCAM-1 Prevents Angiotensin II-Induced Hypertension and Vascular Remodeling in Mice

Adhesion of monocytes to the vascular endothelium frequently leads to an inflammatory response, which contributes to hypertension and vascular remodeling. Vascular cellular adhesion molecule-1 (VCAM-1) plays an important role in leukocyte adhesion and migration during inflammatory diseases. However,...

Full description

Bibliographic Details
Main Authors: Liangqingqing Yin, Jie Bai, Wei-Jia Yu, Ying Liu, Hui-Hua Li, Qiu-Yue Lin
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.825459/full
_version_ 1818331777386676224
author Liangqingqing Yin
Jie Bai
Wei-Jia Yu
Ying Liu
Hui-Hua Li
Hui-Hua Li
Qiu-Yue Lin
author_facet Liangqingqing Yin
Jie Bai
Wei-Jia Yu
Ying Liu
Hui-Hua Li
Hui-Hua Li
Qiu-Yue Lin
author_sort Liangqingqing Yin
collection DOAJ
description Adhesion of monocytes to the vascular endothelium frequently leads to an inflammatory response, which contributes to hypertension and vascular remodeling. Vascular cellular adhesion molecule-1 (VCAM-1) plays an important role in leukocyte adhesion and migration during inflammatory diseases. However, its role in angiotensin (Ang) II -induced hypertension and vascular dysfunction remains largely unknown. Wild-type (WT) mice were administered a VCAM-1 neutralizing antibody (0.1 or 0.2 mg/mouse/day) or IgG control and then infused with Ang II (490 ng kg−1 min−1) or saline continuously for 14 days. Systolic blood pressure (SBP) was measured with a tail-cuff system, pathological changes in the aorta were assessed by histological staining, and vascular relaxation was analyzed an aortic ring assay. Our results indicated that compared with saline infusion, Ang II infusion significantly upregulated VCAM-1 expression in the mouse aorta and serum. Moreover, Ang II infusion markedly increased arterial hypertension, wall thickness, fibrosis, infiltration of Mac-2+ macrophages, reactive oxygen species (ROS) production and vascular relaxation dysfunction. Conversely, blockade of VCAM-1 with a neutralizing antibody substantially alleviated these effects. In vitro experiments further confirmed that the VCAM-1 neutralizing antibody inhibited Ang II-induced macrophage adhesion and migration and DNA damage and oxidative stress in endothelial cells (ECs). In conclusion, these results indicate that blockade of VCAM-1 exerts a protective effect against Ang II-induced arterial hypertension and dysfunction by regulating monocytes adhesion and infiltration into the endothelium and represents a novel therapeutic approach for hypertension.
first_indexed 2024-12-13T13:25:14Z
format Article
id doaj.art-8b555b54c8ac45439dc6938ff70e78da
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-13T13:25:14Z
publishDate 2022-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-8b555b54c8ac45439dc6938ff70e78da2022-12-21T23:44:18ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-02-011310.3389/fphar.2022.825459825459Blocking VCAM-1 Prevents Angiotensin II-Induced Hypertension and Vascular Remodeling in MiceLiangqingqing Yin0Jie Bai1Wei-Jia Yu2Ying Liu3Hui-Hua Li4Hui-Hua Li5Qiu-Yue Lin6Institute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, ChinaInstitute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, ChinaInstitute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, ChinaInstitute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, ChinaInstitute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, ChinaDepartment of Emergency Medicine, Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation, Beijing Chaoyang Hospital, Capital Medical University, Beijing, ChinaInstitute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, ChinaAdhesion of monocytes to the vascular endothelium frequently leads to an inflammatory response, which contributes to hypertension and vascular remodeling. Vascular cellular adhesion molecule-1 (VCAM-1) plays an important role in leukocyte adhesion and migration during inflammatory diseases. However, its role in angiotensin (Ang) II -induced hypertension and vascular dysfunction remains largely unknown. Wild-type (WT) mice were administered a VCAM-1 neutralizing antibody (0.1 or 0.2 mg/mouse/day) or IgG control and then infused with Ang II (490 ng kg−1 min−1) or saline continuously for 14 days. Systolic blood pressure (SBP) was measured with a tail-cuff system, pathological changes in the aorta were assessed by histological staining, and vascular relaxation was analyzed an aortic ring assay. Our results indicated that compared with saline infusion, Ang II infusion significantly upregulated VCAM-1 expression in the mouse aorta and serum. Moreover, Ang II infusion markedly increased arterial hypertension, wall thickness, fibrosis, infiltration of Mac-2+ macrophages, reactive oxygen species (ROS) production and vascular relaxation dysfunction. Conversely, blockade of VCAM-1 with a neutralizing antibody substantially alleviated these effects. In vitro experiments further confirmed that the VCAM-1 neutralizing antibody inhibited Ang II-induced macrophage adhesion and migration and DNA damage and oxidative stress in endothelial cells (ECs). In conclusion, these results indicate that blockade of VCAM-1 exerts a protective effect against Ang II-induced arterial hypertension and dysfunction by regulating monocytes adhesion and infiltration into the endothelium and represents a novel therapeutic approach for hypertension.https://www.frontiersin.org/articles/10.3389/fphar.2022.825459/fullVCAM-1hypertensionmacrophage adhesioninflammationoxidative stressvascular dysfunction
spellingShingle Liangqingqing Yin
Jie Bai
Wei-Jia Yu
Ying Liu
Hui-Hua Li
Hui-Hua Li
Qiu-Yue Lin
Blocking VCAM-1 Prevents Angiotensin II-Induced Hypertension and Vascular Remodeling in Mice
Frontiers in Pharmacology
VCAM-1
hypertension
macrophage adhesion
inflammation
oxidative stress
vascular dysfunction
title Blocking VCAM-1 Prevents Angiotensin II-Induced Hypertension and Vascular Remodeling in Mice
title_full Blocking VCAM-1 Prevents Angiotensin II-Induced Hypertension and Vascular Remodeling in Mice
title_fullStr Blocking VCAM-1 Prevents Angiotensin II-Induced Hypertension and Vascular Remodeling in Mice
title_full_unstemmed Blocking VCAM-1 Prevents Angiotensin II-Induced Hypertension and Vascular Remodeling in Mice
title_short Blocking VCAM-1 Prevents Angiotensin II-Induced Hypertension and Vascular Remodeling in Mice
title_sort blocking vcam 1 prevents angiotensin ii induced hypertension and vascular remodeling in mice
topic VCAM-1
hypertension
macrophage adhesion
inflammation
oxidative stress
vascular dysfunction
url https://www.frontiersin.org/articles/10.3389/fphar.2022.825459/full
work_keys_str_mv AT liangqingqingyin blockingvcam1preventsangiotensiniiinducedhypertensionandvascularremodelinginmice
AT jiebai blockingvcam1preventsangiotensiniiinducedhypertensionandvascularremodelinginmice
AT weijiayu blockingvcam1preventsangiotensiniiinducedhypertensionandvascularremodelinginmice
AT yingliu blockingvcam1preventsangiotensiniiinducedhypertensionandvascularremodelinginmice
AT huihuali blockingvcam1preventsangiotensiniiinducedhypertensionandvascularremodelinginmice
AT huihuali blockingvcam1preventsangiotensiniiinducedhypertensionandvascularremodelinginmice
AT qiuyuelin blockingvcam1preventsangiotensiniiinducedhypertensionandvascularremodelinginmice